Aerovate Therapeutics Ownership | Who Owns Aerovate Therapeutics?
Aerovate Therapeutics Ownership Summary
Aerovate Therapeutics is owned by 1.71% institutional investors, 0.02% insiders, and 98.28% retail investors. Tcg crossover management is the largest institutional shareholder, holding 7.76% of AVTE shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.85% of its assets in Aerovate Therapeutics shares.
AVTE Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Aerovate Therapeutics | 1.71% | 0.02% | 98.28% |
| Sector | Healthcare Stocks | 279.19% | 10.62% | -189.81% |
| Industry | Biotech Stocks | 63.96% | 10.74% | 25.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Tcg crossover management | 2.24M | 7.76% | $5.94M |
| Atlas venture life science advisors | 1.80M | 6.23% | $4.77M |
| Logos global management lp | 1.40M | 4.85% | $3.71M |
| Blackrock | 983.06K | 3.54% | $1.63M |
| Vanguard group | 1.00M | 3.47% | $2.66M |
| Blackrock funding, inc. /de | 975.42K | 3.38% | $2.58M |
| Artal group | 809.60K | 2.91% | $1.34M |
| Affinity asset advisors | 800.00K | 2.77% | $2.12M |
| Jefferies financial group | 600.00K | 2.08% | $1.59M |
| Blackstone | 499.57K | 1.73% | $1.32M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Allostery investments lp | 1.42M | 5.15% | $3.57M |
| Adar1 capital management | 1.46M | 0.68% | $3.67M |
| Sofinnova investments | 3.76M | 0.62% | $9.43M |
| Atlas venture life science advisors | 1.80M | 0.58% | $4.77M |
| Tcg crossover management | 2.24M | 0.58% | $5.94M |
| Logos global management lp | 1.40M | 0.43% | $3.71M |
| Ra capital management | 9.19M | 0.39% | $23.07M |
| Affinity asset advisors | 800.00K | 0.28% | $2.12M |
| Braidwell lp | 1.44M | 0.13% | $3.62M |
| Fifth lane capital, lp | 50.00K | 0.12% | $83.00K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Logos global management lp | 1.40M | 0.43% | 1.40M |
| Artal group | 809.60K | 0.03% | 809.60K |
| Jefferies financial group | 600.00K | 0.01% | 600.00K |
| Allostery investments lp | 1.42M | 5.15% | 570.88K |
| Adar1 capital management | 1.46M | 0.68% | 533.22K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Deerfield management company, l.p. (series c) | - | - | -1.41M |
| Frazier life sciences management | - | - | -1.20M |
| Cormorant asset management, lp | - | - | -1.07M |
| Great point partners | - | - | -887.69K |
| Driehaus capital management | - | - | -794.99K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Logos global management lp | 1.40M | 0.43% | 1.40M | $3.71M |
| Artal group | 809.60K | 0.03% | 809.60K | $1.34M |
| Jefferies financial group | 600.00K | 0.01% | 600.00K | $1.59M |
| Blackstone | 499.57K | 0.01% | 499.57K | $1.32M |
| Deltec asset management | 194.12K | 0.10% | 194.12K | $514.43K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -2.00 |
| Gamma investing | -80.00 |
| Capital performance advisors llp | -80.00 |
| Fortitude family office | -416.00 |
| Metropolitan life insurance co/ny | -701.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 8 | -90.36% | 17,315,633 | -42.60% | 1 | 0.02% | 3 | -94.12% | 1 | -92.31% |
| Dec 31, 2024 | 82 | 6.49% | 30,155,830 | 9.09% | 104 | 1.14% | 50 | 28.21% | 13 | -18.75% |
| Sep 30, 2024 | 77 | -17.20% | 27,644,291 | 1.70% | 95 | 1.00% | 39 | -37.10% | 16 | 14.29% |
| Jun 30, 2024 | 93 | 17.72% | 27,181,983 | -4.43% | 97 | 0.93% | 62 | 55.00% | 14 | -39.13% |
| Mar 31, 2024 | 79 | 25.40% | 28,443,127 | 0.96% | 102 | 0.89% | 40 | 29.03% | 23 | 35.29% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 536.62K | 1.85% | 52.67K |
| iShares Russell 2000 ETF | 458.98K | 1.58% | -3.96K |
| Vanguard VIF Small Co Gr | 213.89K | 0.74% | -76.53K |
| Vanguard Institutional Extnd Mkt Idx Tr | 202.52K | 0.70% | - |
| State St Russell Sm/Mid Cp® Indx SL Cl I | 172.19K | 0.59% | - |
| State St Russell Sm/Mid Cp® Indx NL Cl C | 172.19K | 0.59% | - |
| Bridge Builder Tax Managed Sm/Md Cp | 124.13K | 0.43% | - |
| iShares Russell 2000 Growth ETF | 110.99K | 0.38% | -528.00 |
| Vanguard Russell 2000 ETF | 62.88K | 0.22% | 1.38K |
| Fidelity Enhanced Small Cap ETF | 48.26K | 0.17% | -336.00 |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 17, 2024 | RA CAPITAL MANAGEMENT, L.P. | Buy | $1.55M | |
| Jun 14, 2024 | Eldridge George A | SEE REMARKS | Sell | $375.45K |
| Jun 14, 2024 | Verwijs Marinus | CHIEF TECHNICAL OFFICER | Sell | $265.00K |
| Jun 13, 2024 | Gillies Hunter | CHIEF MEDICAL OFFICER | Sell | $147.00K |
| May 17, 2024 | Gillies Hunter | CHIEF MEDICAL OFFICER | Sell | $82.45K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q3 | - | - |
| 2024 Q2 | 1 | 29 |
| 2024 Q1 | - | 23 |
| 2023 Q4 | - | 12 |
| 2023 Q3 | - | 10 |
AVTE Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools